Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS

被引:242
|
作者
Alimonti, JB [1 ]
Ball, TB [1 ]
Fowke, KR [1 ]
机构
[1] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB R3E 0W3, Canada
来源
关键词
D O I
10.1099/vir.0.19110-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
AIDS, caused by the retroviruses human immunodeficiency virus type 1 and type 2 (HIV-1 and HIV-2), has reached pandemic proportions. Therefore, it is critical to understand how HIV causes AIDS so that appropriate therapies can be formulated. Primarily, HIV infects and kills CD4(+) T lymphocytes, which function as regulators and amplifiers of the immune response. In the absence of effective anti-retroviral therapy, the hallmark decrease in CD4(+) T lymphocytes during AIDS results in a weakened immune system, impairing the body's ability to fight infections or certain cancers such that death eventually ensues. The major mechanism for CD4(+) T cell depletion is programmed cell death (apoptosis), which can be induced by HIV through multiple pathways. Death of HIV-infected cells can result from the propensity of infected lymphocytes to form short-lived syncytia or from an increased susceptibility of the cells to death. However, the apoptotic cells appear to be primarily uninfected bystander cells and are eradicated by two different mechanisms: either a Fas-mediated mechanism during activation-induced cell death (AICD), or as a result of HIV proteins (Tat, gp120, Nef, Vpu) released from infected cells stimulating apoptosis in uninfected bystander cells. There is also evidence that as AIDS progresses cytokine dysregulation occurs, and the overproduction of type-2 cytokines (IL-4, IL-10) increases susceptibility to ACID whereas type-1 cytokines (IL-12, IFN-gamma) may be protective. Clearly there are multiple causes of CD4(+) T lymphocyte apoptosis in AIDS and therapies that block or decrease that death could have significant clinical benefit.
引用
收藏
页码:1649 / 1661
页数:13
相关论文
共 50 条
  • [31] Timing of antiretroviral therapy initiation after diagnosis of recent human immunodeficiency virus infection and CD4+ T-cell recovery
    Ding, Y.
    Duan, S.
    Wu, Z.
    Ye, R.
    Yang, Y.
    Yao, S.
    Wang, J.
    Xiang, L.
    Jiang, Y.
    Lu, L.
    Jia, M.
    Detels, R.
    He, N.
    CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 (03) : 290.e5 - 290.e8
  • [32] MOLECULAR SPECIFICITIES OF CD4+ T-CELL-REACTIVE IGM IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV-1) INFECTION
    SILVESTRIS, F
    CAFFORIO, P
    ROMITO, A
    DAMMACCO, F
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1994, 70 (01): : 40 - 46
  • [33] Influence of HCV genotype and co-infection with human immunodeficiency virus on CD4+ and CD8+ T-cell responses to hepatitis C virus
    Capa, Laura
    Soriano, Vincent
    Garcia-Samaniego, Javier
    Nunez, Marina
    Romero, Miriam
    Cascajero, Almudena
    Munoz, Fernando
    Gonzalez-Lahoz, Juan
    Benito, Jose M.
    JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (05) : 503 - 510
  • [34] ACTIVE AND DORMANT HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION OF CD4+ LYMPHOCYTES AND MACROPHAGES
    HAASE, AT
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S77 - S77
  • [35] Correlates of preserved CD4+ T cell homeostasis during natural, nonpathogenic simian immunodeficiency virus infection of sooty mangabeys:: Implications for AIDS pathogenesis
    Sumpter, Beth
    Dunham, Richard
    Gordon, Shari
    Engram, Jessica
    Hennessy, Margaret
    Kinter, Audrey
    Paiardini, Mirko
    Cervasi, Barbara
    Klatt, Nichole
    McClure, Harold
    Milush, Jeffrey M.
    Staprans, Silvija
    Sodora, Donald L.
    Silvestri, Guido
    JOURNAL OF IMMUNOLOGY, 2007, 178 (03): : 1680 - 1691
  • [36] AGE-ADJUSTED CD4+ LYMPHOCYTE PARAMETERS IN HEALTHY-CHILDREN AT RISK FOR INFECTION WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS
    WAECKER, NJ
    ASCHER, DP
    ROBB, ML
    MORIARTY, R
    KORBER, M
    RICKMAN, WJ
    BUTZIN, CA
    FISCHER, GW
    KUSKIE, M
    VINCENT, J
    GOLDBERG, D
    OTTOLINI, M
    CIESLAK, T
    HEMMING, V
    CLINICAL INFECTIOUS DISEASES, 1993, 17 (01) : 123 - 125
  • [37] T cell apoptosis in human immunodeficiency virus type 1 infection:: Is there a relationship between CD95 sensitivity and thymic regeneration of CD4+ T cells?
    Böhler, T
    JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (09): : 1225 - 1226
  • [38] INFLECTION POINT OF CD4+ CELL DECLINE IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION AND POSSIBLE PREDICTORS
    LIU, Z
    GIORGI, JV
    VISSCHER, BV
    DETELS, R
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 139 (11) : S29 - S29
  • [39] Human immunodeficiency virus type 1 Nef protein on the cell surface is cytocidal for human CD4+ T cells
    Fujii, Y
    Otake, K
    Tashiro, M
    Adachi, A
    FEBS LETTERS, 1996, 393 (01) : 105 - 108
  • [40] Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens
    Aandahl, EM
    Michaëlsson, J
    Moretto, WJ
    Hecht, FA
    Nixon, DF
    JOURNAL OF VIROLOGY, 2004, 78 (05) : 2454 - 2459